Daphna Mokady

Daphna Mokady is a highly experienced researcher with 15+ years of proven track record in leading projects in a broad spectrum of biomedical research. After completing her Ph.D. at Tel Aviv University, Daphna’s first post-doc was directed at the development of a novel zebrafish model for Alzheimer's disease, enabling exciting imaging-based monitoring of whole-brain neural activity. In her second post-doc at UHN, Toronto, Daphna has identified a signal transduction pathway involved in the resistance of ovarian cancer cells to chemotherapeutic agents and has performed drug screens targeted at re-sensitizing the cancer cells to the currently used first-line treatment.

Throughout her work, Daphna has established successful collaborations with leading pharmaceutical companies, top researchers, and key opinion leaders in various fields. Daphna’s broad experience has allowed her to promote innovative ideas and lead pioneering research projects with demonstrated results.